Loading…
On this episode of Stock Movers: - Novartis (NOVN) shares are lower as it suffered its third clinical-trial setback in a week after a treatment for a rare muscle-wasting disease failed a late-stage study. - Boston Scientific (BSX) shares are moving on news it said that fallout…
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.